418 results on '"Garcia Tsao G"'
Search Results
2. Early trends in cystatin c and outcomes in patients with cirrhosis and acute kidney injury
3. Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation
4. Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection
5. O-6 NON-INVASIVE ASSESSMENT OS HEPATIC FIBROSIS BEFORE AND AFTER HCV CURE AND CORRELATION WITH CLINICAL OUTCOMES
6. Supplement to: Management of varices in cirrhosis
7. Supplement to: Management of varices and variceal hemorrhage in cirrhosis
8. Sepsis in cirrhosis: report on the 7th meeting of the international ascites club
9. Effect of Lactobacillus-Fermented Diets on Bacterial Translocation and Intestinal Flora in Experimental Prehepatic Portal Hypertension
10. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
11. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders
12. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
13. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
14. Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis
15. LBP-019 - 13C-methacetin breath test is a highly accurate non-invasive point of care test for detecting CSPH in patients with NASH
16. LBO-001 - A multicenter, randomized, double-blind, PLB-controlled trial of Galectin-3 inhibitor (GR-MD-02) in patients with NASH cirrhosis and portal hypertension
17. GS-015 - Primary spontaneous bacterial peritonitis prophylaxis is associated with greater ICU admission and 30-day mortality compared to secondary spontaneous bacterial peritonitis prophylaxis
18. FRI-022 - NACSELD acute-on-chronic liver failure (NACSELD-ACLF) predicts 30-day mortality in admitted cirrhotic patients
19. FRI-025 - Albumin use and acute kidney injury in a large real-world analysis of cirrhotic inpatients
20. THU-209 - In hepatitis C virus-related advanced fibrosis and cirrhosis, early decline of liver stiffness following antiviral therapy with DAAs is related to decline in liver inflammation
21. LBP-523 - A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysis
22. LBP-516 - 13C-Methacetin Breath Test accurately assesses clinically significant portal hypertension in patients with NASH cirrhosis
23. THU-373 - Predicting Mortality after Discharge from Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score
24. THU-347 - Progressive Alterations in Systemic and Cardiopulmonary Hemodynamics Occur in Patients with Cirrhosis and Predict Death in Decompensated Cirrhosis
25. THU-334 - In-Hospital Mortality Related to Hepatic Encephalopathy is Independent of Acute-On-Chronic Liver Failure and Varies Significantly across North America: Nacseld Experience
26. THU-001 - Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with a Lower Meld, less Inflammation and an Improved Survival
27. P0199 : Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient outcomes
28. P0120 : The 3-month readmission rate remains unacceptably high in a large multi-center cohort of cirrhotic patients
29. P0119 : Validation Of The NACSELD Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) score in an independent multicenter cohort
30. O072 : Statin use significantly decreases decompensation and death in veterans with hepatitis C-related compensated cirrhosis
31. P1013 MEASUREMENT OF LIVER AND SPLEEN STIFFNESS BY ARFI ELASTOGRAPHY: INTRA- AND INTER-OBSERVER VARIABILITY AND PREDICTORS OF VARIABILITY
32. P943 DIFFERENCES IN CREATININE BETWEEN GENDERS COULD DISADVANTAGE INFECTED CIRRHOTIC WOMEN: THE NACSELD EXPERIENCE
33. P905 THE RISK OF DELISTING OR DEATH IN LIVER TRANSPLANT CANDIDATES INCREASES FOLLOWING INFECTIONS: RESULTS FROM THE NACSELD CONSORTIUM
34. P502 SPONTANEOUS BACTERIAL PERITONITIS AND BACTEREMIA PREDICT MORTALITY IN CIRRHOSIS DESPITE PROPHYLACTIC MEASURES: A PROSPECTIVE MULTI-CENTER STUDY FROM NACSELD
35. 226 LONG-TERM ANTIBIOTIC AND PROTON-PUMP INHIBITOR USE ARE STRONG PREDICTORS OF RECURRENT INFECTIONS IN CIRRHOSIS: A PROSPECTIVE MULTI-CENTER STUDY FROM NACSELD
36. 83 THE NEW CONSENSUS DEFINITION OF ACUTE KIDNEY INJURY IS VALID IN PREDICTING MORTALITY IN HOSPITALIZED INFECTED CIRRHOTIC PATIENTS: THE NACSELD EXPERIENCE
37. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research.
38. Spontaneous Bacterial Peritonitis - Prophylaxis and Treatment.
39. Portal hypertension.
40. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
41. Portal hypertension.
42. Portal hypertension.
43. Outpatient liver biopsy: how safe is it?
44. A comparative clinical study of idiopathic portal hypertension, extrahepatic portal vein thrombosis, and cirrhosis.
45. 233 QUANTITATIVE HISTOLOGICAL ASSESSMENT IN CIRRHOSIS: SEPTAL THICKNESS PREDICTS CLINICAL DECOMPENSATION
46. 317 PROGNOSTIC INDICATORS OF SURVIVAL IN COMPENSATED AND DECOMPENSATED STAGES OF LIVER CIRRHOSIS: VALIDATION OF A 4-STAGE CLASSIFICATION
47. Treatment of ascites with A single total paracentesis.
48. 103 Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor
49. Ultrasound parameters in the prediction of clinically significant portal hypertension (CS-PHT) in compensated cirrhosis
50. Recommendations for probiotic use--2008.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.